Centessa Pharmaceuticals
(CNTA)
undefined
undefined%
At close: undefined
16.57
-0.06%
After-hours Dec 13, 2024, 04:00 PM EST
Centessa Pharmaceuticals Analyst Ratings
Total Analysts
6
Consensus Rating
Buy
Price Target
27
Upside
62.85
Ratings History
| Analyst | Firm | Rating | Action | Price Target | Date |
| Guggenheim | Strong Buy | Maintains | 24 28 | Nov 15, 2024 | |
Jeffrey Hung (0)
| Morgan Stanley | Buy | Upgrades | 11 26 | Sep 19, 2024 |
Mayank Mamtani (1.48)
| B. Riley Securities | Buy | Initiates | 33 | Sep 19, 2024 |
Trade Smarter, Not Harder
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options Data
- Instant access to live options data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.